Viimeisimmät kokeilut

EudraCT Number: 2004-001749-13 Sponsor Protocol Number: P04071 Start Date: 2005-02-22
Sponsor Name: AESCA Pharma GesmbH
Full Title: Randomized Phase II Study: Temozolomide (TMZ) Concomitant to Radiotherapy followed by sequential TMZ in Advanced NSCLC Patients with CNS Metastasis versus Radiotherapy alone
Medical condition: Patients with non small cell lung cancer (NSCLC) have a high risk of developing brain metastasis, up to 40% as evaluated in autopsy studies. These patients are often heavily symptomatic and their l...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-000202-49 Sponsor Protocol Number: CN138-134 Start Date: 2005-02-22
Sponsor Name: Bristol-Myers Squibb International Corporation
Full Title: Efficacy of Aripiprazole in Combination with Valproate or Lithium in the Treatment of Mania in Patients with Bipolar I Disorder Partially Nonresponsive to Valproate or Lithium Monotherapy Revised...
Medical condition: Bipolar disorder
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: EE (Completed) HU (Completed) ES (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2005-000728-18 Sponsor Protocol Number: VT002 Start Date: 2005-02-21
Sponsor Name: AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE
Full Title: An experiment of phase II open label about safety and Mifepristone vgx-410 anti-HIV activity on patients affected by HIV-1
Medical condition: Anti-HIV drug
Disease: Version SOC Term Classification Code Term Level
10000807 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004269-14 Sponsor Protocol Number: A5091026 Start Date: 2005-02-21
Sponsor Name: Pfizer AB
Full Title: Phase 3, Multi-center, double-blind, randomized, parallel group study of the efficacy, safety, and tolerability of fixed combination torcetrapib (CP-529,414)/Atorvastatin administered orally, once ...
Medical condition: Heterozygous Familial Hypercholesterolemia
Disease: Version SOC Term Classification Code Term Level
7.1 10057079 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) DK (Completed) IS (Completed)
Trial results: View results
EudraCT Number: 2004-002208-14 Sponsor Protocol Number: Protocol v.1.2 30/08/04 Start Date: 2005-02-21
Sponsor Name: Cardiff and Vale NHS Trust
Full Title: Duration of Amiodarone therapy required for new post cardiac surgery atrial fibrillation.
Medical condition: Atrial fibrillation following cardiac surgery.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2004-004267-30 Sponsor Protocol Number: Gebro-III-21-10 Start Date: 2005-02-21
Sponsor Name: Gebro Pharma GmbH
Full Title: Efficacy and Tolerability of Dexibuprofen Film coated tablets in Comparison to Ibuprofen in Children and Adolescents with Tonsillopharyngitis
Medical condition: Tonsillopharyngitis
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2004-004748-27 Sponsor Protocol Number: Acadmed CTU01/05 Start Date: 2005-02-21
Sponsor Name: Hull and east Yorkshire Hospitals Trust, Research and Deveopment, admin porta cabin
Full Title: An 8 week, double-blind, randomised, parallel group study to investigate the effect of 20 mg Esomeprazole (Nexium) tablets Twice daily versus placebo on symptoms associated with chronic cough due ...
Medical condition: We will be using Nexium to treat gastro-oesophageal reflux and in return this will reduce reflux related cough ( a manifestation of reflux)
Disease: Version SOC Term Classification Code Term Level
3 10013946 2
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-004339-78 Sponsor Protocol Number: FOLFOX6 Start Date: 2005-02-18
Sponsor Name: AZIENDA OSPEDALIERA POLICLINICO DI MODENA
Full Title: FOLFOX6 TRIAL: TREATMENT OF THE FIRST LINE OF LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER. CLINICAL TRIAL ABOUT BIOMOLECULAR PREDICTIVE FACTORS
Medical condition: Locally Advanced and Metastatic Gastric Cancer
Disease: Version SOC Term Classification Code Term Level
6.1 10017768 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-002945-10 Sponsor Protocol Number: V501-020 Start Date: 2005-02-18
Sponsor Name: Suomen MSD OY
Full Title: A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16, and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related Anogenital Warts, and the I...
Medical condition: Prevention of Human Papillomavirus Infections
Disease: Version SOC Term Classification Code Term Level
7.0 10063001 LLT
Population Age: Adolescents, Under 18, Adults Gender: Male
Trial protocol: FI (Completed) SE (Completed) DE (Completed) ES (Completed) Outside EU/EEA
Trial results: View results
EudraCT Number: 2004-001729-11 Sponsor Protocol Number: CR040301 Start Date: 2005-02-18
Sponsor Name: EBEWE Pharma Ges.m.b.H Nfg.KG
Full Title: A prospective, randomised, placebo controlled, double blind trial about safety and efficacy of combined treatment with Alteplase (rt-PA) and Cerebrolysin in acute ischemic hemispheric stroke
Medical condition: Clinical diagnosis of ischemic stroke causing a measurable neurological deficit defined as impairment of language, motor function, cognition and/or gaze, vision or neglect. Ischemic stroke is defin...
Disease: Version SOC Term Classification Code Term Level
6.0 10055221 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) SK (Completed) CZ (Completed) SI (Completed)
Trial results: View results

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa